HMMR and neoplasm: In tumourigenesis, the over-expression of RHAMM may be an indicator of adverse prognosis [29] and within the CNS, glioma stem cells (GSC), neural stem and progenitor cells (NSC/NPC) are amongst the most active in GBM, taking part in the development and differentiation of the tumour.